CVS Health Corporation (0HRS.L)
USD 67.18
(-5.26%)
USD 67.18
(-5.26%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 79.38 Billion USD | 12.23% |
| 2022 | 70.73 Billion USD | -6.93% |
| 2021 | 75.99 Billion USD | -10.63% |
| 2020 | 85.04 Billion USD | -4.45% |
| 2019 | 89 Billion USD | 21.21% |
| 2018 | 73.42 Billion USD | 171.94% |
| 2017 | 27 Billion USD | -1.92% |
| 2016 | 27.53 Billion USD | 0.24% |
| 2015 | 27.46 Billion USD | 112.0% |
| 2014 | 12.95 Billion USD | -3.34% |
| 2013 | 13.4 Billion USD | 36.37% |
| 2012 | 9.82 Billion USD | -1.86% |
| 2011 | 10.01 Billion USD | -0.43% |
| 2010 | 10.05 Billion USD | -10.0% |
| 2009 | 11.17 Billion USD | -4.93% |
| 2008 | 11.75 Billion USD | 12.14% |
| 2007 | 10.48 Billion USD | 107.26% |
| 2006 | 5.05 Billion USD | 131.03% |
| 2005 | 2.18 Billion USD | -22.98% |
| 2004 | 2.84 Billion USD | 164.06% |
| 2003 | 1.07 Billion USD | -3.31% |
| 2002 | 1.11 Billion USD | 3.78% |
| 2001 | 1.07 Billion USD | -6.57% |
| 2000 | 1.14 Billion USD | 11.8% |
| 1999 | 1.02 Billion USD | -3.26% |
| 1998 | 1.06 Billion USD | 43.63% |
| 1997 | 739 Million USD | 143.33% |
| 1996 | 303.7 Million USD | -20.02% |
| 1995 | 379.7 Million USD | -28.53% |
| 1994 | 531.3 Million USD | 23.04% |
| 1993 | 431.8 Million USD | 6.33% |
| 1992 | 406.1 Million USD | -14.83% |
| 1991 | 476.8 Million USD | 9.99% |
| 1990 | 433.5 Million USD | 9.11% |
| 1989 | 397.3 Million USD | 572.25% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 81.79 Billion USD | 3.03% |
| 2024 Q2 | 83.82 Billion USD | 2.48% |
| 2023 Q4 | 79.38 Billion USD | -0.89% |
| 2023 FY | 79.38 Billion USD | 12.23% |
| 2023 Q1 | 76.47 Billion USD | 8.12% |
| 2023 Q2 | 82.13 Billion USD | 7.4% |
| 2023 Q3 | 80.09 Billion USD | -2.48% |
| 2022 Q1 | 75.91 Billion USD | -0.11% |
| 2022 Q2 | 74.17 Billion USD | -2.3% |
| 2022 Q3 | 71.07 Billion USD | -4.18% |
| 2022 Q4 | 70.73 Billion USD | -0.48% |
| 2022 FY | 70.73 Billion USD | -6.93% |
| 2021 Q3 | 78.65 Billion USD | -1.25% |
| 2021 Q4 | 75.99 Billion USD | -3.38% |
| 2021 FY | 75.99 Billion USD | -10.63% |
| 2021 Q1 | 82.31 Billion USD | -3.2% |
| 2021 Q2 | 79.65 Billion USD | -3.24% |
| 2020 Q3 | 87.27 Billion USD | -5.19% |
| 2020 FY | 85.04 Billion USD | -4.45% |
| 2020 Q1 | 92.31 Billion USD | 3.73% |
| 2020 Q2 | 92.05 Billion USD | -0.29% |
| 2020 Q4 | 85.04 Billion USD | -2.56% |
| 2019 Q1 | 95.55 Billion USD | 30.13% |
| 2019 Q3 | 89.67 Billion USD | -2.44% |
| 2019 Q2 | 91.92 Billion USD | -3.8% |
| 2019 Q4 | 89 Billion USD | -0.75% |
| 2019 FY | 89 Billion USD | 21.21% |
| 2018 FY | 73.42 Billion USD | 171.94% |
| 2018 Q4 | 73.42 Billion USD | 16.77% |
| 2018 Q3 | 62.88 Billion USD | -3.41% |
| 2018 Q2 | 65.1 Billion USD | 0.02% |
| 2018 Q1 | 65.09 Billion USD | 141.07% |
| 2017 Q4 | 27 Billion USD | 4.7% |
| 2017 FY | 27 Billion USD | -1.92% |
| 2017 Q3 | 25.78 Billion USD | -3.64% |
| 2017 Q2 | 26.76 Billion USD | -2.44% |
| 2017 Q1 | 27.43 Billion USD | -0.36% |
| 2016 Q2 | 28.63 Billion USD | 4.25% |
| 2016 Q1 | 27.46 Billion USD | 0.02% |
| 2016 FY | 27.53 Billion USD | 0.24% |
| 2016 Q3 | 26.73 Billion USD | -6.65% |
| 2016 Q4 | 27.53 Billion USD | 2.99% |
| 2015 Q1 | 12.76 Billion USD | -1.49% |
| 2015 FY | 27.46 Billion USD | 112.0% |
| 2015 Q4 | 27.46 Billion USD | 0.89% |
| 2015 Q3 | 27.22 Billion USD | 107.09% |
| 2015 Q2 | 13.14 Billion USD | 3.0% |
| 2014 Q1 | 13.41 Billion USD | 0.06% |
| 2014 Q3 | 13.05 Billion USD | -2.36% |
| 2014 Q4 | 12.95 Billion USD | -0.77% |
| 2014 FY | 12.95 Billion USD | -3.34% |
| 2014 Q2 | 13.37 Billion USD | -0.29% |
| 2013 Q1 | 9.66 Billion USD | -1.67% |
| 2013 FY | 13.4 Billion USD | 36.37% |
| 2013 Q4 | 13.4 Billion USD | 31.33% |
| 2013 Q3 | 10.2 Billion USD | 8.84% |
| 2013 Q2 | 9.37 Billion USD | -2.98% |
| 2012 Q1 | 9.21 Billion USD | -8.02% |
| 2012 FY | 9.82 Billion USD | -1.86% |
| 2012 Q4 | 9.82 Billion USD | -2.11% |
| 2012 Q3 | 10.04 Billion USD | 6.66% |
| 2012 Q2 | 9.41 Billion USD | 2.19% |
| 2011 Q2 | 11.08 Billion USD | 13.39% |
| 2011 FY | 10.01 Billion USD | -0.43% |
| 2011 Q3 | 10.76 Billion USD | -2.85% |
| 2011 Q4 | 10.01 Billion USD | -7.0% |
| 2011 Q1 | 9.77 Billion USD | -2.8% |
| 2010 Q1 | 11.37 Billion USD | 1.77% |
| 2010 FY | 10.05 Billion USD | -10.0% |
| 2010 Q4 | 10.05 Billion USD | -9.73% |
| 2010 Q3 | 11.14 Billion USD | -6.86% |
| 2010 Q2 | 11.96 Billion USD | 5.17% |
| 2009 Q1 | 11.12 Billion USD | -5.33% |
| 2009 Q3 | 11.96 Billion USD | 8.37% |
| 2009 Q4 | 11.17 Billion USD | -6.56% |
| 2009 Q2 | 11.03 Billion USD | -0.82% |
| 2009 FY | 11.17 Billion USD | -4.93% |
| 2008 Q3 | 9.72 Billion USD | 3.75% |
| 2008 FY | 11.75 Billion USD | 12.14% |
| 2008 Q1 | 9.73 Billion USD | -7.1% |
| 2008 Q2 | 9.37 Billion USD | -3.72% |
| 2008 Q4 | 11.75 Billion USD | 20.85% |
| 2007 Q4 | 10.48 Billion USD | 14.43% |
| 2007 Q3 | 9.16 Billion USD | -2.51% |
| 2007 Q1 | 6.81 Billion USD | 34.67% |
| 2007 FY | 10.48 Billion USD | 107.26% |
| 2007 Q2 | 9.39 Billion USD | 37.96% |
| 2006 FY | 5.05 Billion USD | 131.03% |
| 2006 Q2 | 6.28 Billion USD | 193.19% |
| 2006 Q1 | 2.14 Billion USD | -2.01% |
| 2006 Q3 | 6.48 Billion USD | 3.13% |
| 2006 Q4 | 5.05 Billion USD | -22.03% |
| 2005 Q3 | 2.79 Billion USD | -1.83% |
| 2005 Q4 | 2.18 Billion USD | -21.56% |
| 2005 Q1 | 2.97 Billion USD | 4.56% |
| 2005 FY | 2.18 Billion USD | -22.98% |
| 2005 Q2 | 2.84 Billion USD | -4.34% |
| 2004 Q1 | 776 Million USD | -27.9% |
| 2004 FY | 2.84 Billion USD | 164.06% |
| 2004 Q2 | 775.8 Million USD | -0.03% |
| 2004 Q3 | 2.93 Billion USD | 277.95% |
| 2004 Q4 | 2.84 Billion USD | -3.07% |
| 2003 FY | 1.07 Billion USD | -3.31% |
| 2003 Q2 | 1.1 Billion USD | -0.02% |
| 2003 Q3 | 1.1 Billion USD | -0.03% |
| 2003 Q4 | 1.07 Billion USD | -2.83% |
| 2003 Q1 | 1.1 Billion USD | -0.44% |
| 2002 Q4 | 1.11 Billion USD | 12.19% |
| 2002 Q3 | 992.2 Million USD | -24.98% |
| 2002 Q2 | 1.32 Billion USD | -11.91% |
| 2002 Q1 | 1.5 Billion USD | 39.98% |
| 2002 FY | 1.11 Billion USD | 3.78% |
| 2001 Q3 | 1.46 Billion USD | 9.25% |
| 2001 Q2 | 1.33 Billion USD | -4.99% |
| 2001 Q1 | 1.4 Billion USD | 22.63% |
| 2001 FY | 1.07 Billion USD | -6.57% |
| 2001 Q4 | 1.07 Billion USD | -26.59% |
| 2000 FY | 1.14 Billion USD | 11.8% |
| 2000 Q2 | 1.54 Billion USD | 3.2% |
| 2000 Q3 | 1.47 Billion USD | -4.45% |
| 2000 Q4 | 1.14 Billion USD | -22.3% |
| 2000 Q1 | 1.49 Billion USD | 45.92% |
| 1999 Q1 | 1.11 Billion USD | 4.81% |
| 1999 Q3 | 1.18 Billion USD | -8.87% |
| 1999 Q4 | 1.02 Billion USD | -13.21% |
| 1999 Q2 | 1.29 Billion USD | 16.69% |
| 1999 FY | 1.02 Billion USD | -3.26% |
| 1998 Q1 | 935.7 Million USD | 26.62% |
| 1998 Q3 | 989.4 Million USD | 2.82% |
| 1998 Q4 | 1.06 Billion USD | 7.28% |
| 1998 FY | 1.06 Billion USD | 43.63% |
| 1998 Q2 | 962.3 Million USD | 2.84% |
| 1997 Q1 | 294 Million USD | -3.19% |
| 1997 Q2 | 591.7 Million USD | 101.26% |
| 1997 FY | 739 Million USD | 143.33% |
| 1997 Q4 | 739 Million USD | 135.95% |
| 1997 Q3 | 313.2 Million USD | -47.07% |
| 1996 Q3 | 325.3 Million USD | -21.29% |
| 1996 FY | 303.7 Million USD | -20.02% |
| 1996 Q1 | 827.5 Million USD | 117.94% |
| 1996 Q2 | 413.3 Million USD | -50.05% |
| 1996 Q4 | 303.7 Million USD | -6.64% |
| 1995 FY | 379.7 Million USD | -28.53% |
| 1995 Q4 | 379.7 Million USD | -70.15% |
| 1995 Q3 | 1.27 Billion USD | 11.96% |
| 1995 Q2 | 1.13 Billion USD | 4.1% |
| 1995 Q1 | 1.09 Billion USD | 105.44% |
| 1994 Q4 | 531.3 Million USD | -51.32% |
| 1994 Q3 | 1.09 Billion USD | 25.34% |
| 1994 Q2 | 870.8 Million USD | 4.2% |
| 1994 Q1 | 835.7 Million USD | 93.54% |
| 1994 FY | 531.3 Million USD | 23.04% |
| 1993 FY | 431.8 Million USD | 6.33% |
| 1993 Q1 | 804 Million USD | 97.98% |
| 1993 Q2 | 863 Million USD | 7.34% |
| 1993 Q3 | 1 Billion USD | 16.23% |
| 1993 Q4 | 431.8 Million USD | -56.95% |
| 1992 Q2 | 998.3 Million USD | 1.58% |
| 1992 FY | 406.1 Million USD | -14.83% |
| 1992 Q4 | 406.1 Million USD | -62.8% |
| 1992 Q1 | 982.8 Million USD | 106.12% |
| 1992 Q3 | 1.09 Billion USD | 9.35% |
| 1991 FY | 476.8 Million USD | 9.99% |
| 1991 Q1 | 857.3 Million USD | 97.76% |
| 1991 Q4 | 476.8 Million USD | -49.17% |
| 1991 Q3 | 938.1 Million USD | 6.57% |
| 1991 Q2 | 880.3 Million USD | 2.68% |
| 1990 FY | 433.5 Million USD | 9.11% |
| 1990 Q1 | 575.6 Million USD | 44.88% |
| 1990 Q3 | 1.16 Billion USD | 106.31% |
| 1990 Q4 | 433.5 Million USD | -62.94% |
| 1990 Q2 | 567 Million USD | -1.49% |
| 1989 FY | 397.3 Million USD | 572.25% |
| 1989 Q1 | 185.6 Million USD | 214.04% |
| 1989 Q2 | 408.9 Million USD | 120.31% |
| 1989 Q3 | 592.4 Million USD | 44.88% |
| 1989 Q4 | 397.3 Million USD | -32.93% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -662380.18% |
| Accuray Incorporated | 172.15 Million USD | -46012.247% |
| Align Technology, Inc. | 96.96 Million USD | -81767.214% |
| Elevance Health Inc. | 25.12 Billion USD | -216.023% |
| AxoGen, Inc. | 69.29 Million USD | -114465.895% |
| Boston Scientific Corporation | 9.09 Billion USD | -772.65% |
| Cardinal Health, Inc. | 5.6 Billion USD | -1315.315% |
| Centene Corporation | 17.69 Billion USD | -348.528% |
| DaVita Inc. | 11.11 Billion USD | -614.124% |
| HCA Healthcare, Inc. | 41.85 Billion USD | -89.649% |
| Hologic, Inc. | 2.53 Billion USD | -3032.052% |
| Humana Inc. | 10.21 Billion USD | -677.294% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | -8275.005% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | -1233.261% |
| Masimo Corporation | 970 Million USD | -8084.021% |
| McKesson Corporation | 5.47 Billion USD | -1350.749% |
| Patterson Companies, Inc. | 762.94 Million USD | -10305.143% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | -1378.581% |
| ResMed Inc. | 873.93 Million USD | -8983.628% |
| Henry Schein, Inc. | 2.74 Billion USD | -2796.206% |
| Teladoc Health, Inc. | 1.59 Billion USD | -4885.628% |
| Universal Health Services, Inc. | 5.36 Billion USD | -1379.234% |
| Veeva Systems Inc. | 55.77 Million USD | -142230.793% |
| Baxter International Inc. | 14.36 Billion USD | -452.666% |
| Becton, Dickinson and Company | 15.87 Billion USD | -399.937% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -88302.004% |
| Danaher Corporation | 19.35 Billion USD | -310.131% |
| Stryker Corporation | 12.99 Billion USD | -510.889% |
| Medtronic plc | 24.96 Billion USD | -218.011% |